Biokinesis Overview

  • Founded

  • 2011

Founded
  • Status

  • Acquired/​Merged

  • Employees

  • 1

Employees
  • Latest Deal Type

  • M&A

Biokinesis General Information

Description

Operator of a biotechnology company aimed at developing an anticancer compound targeting the Golgi apparatus. The company is currently operating in stealth mode.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Diaccurate
Primary Office
  • 5 rue de la Baume
  • 75008 Paris
  • France

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biokinesis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Dec-2020 Completed Stealth
1. Early Stage VC 01-Oct-2011 Completed Stealth
To view Biokinesis’s complete valuation and funding history, request access »

Biokinesis Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biokinesis Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Truffle Capital PE/Buyout Minority 000 0000 000000 0
To view Biokinesis’s complete investors history, request access »

Ready to get started?

Request a free trial